270 related articles for article (PubMed ID: 30682900)
1. Early-stage predictors for treatment responses in patients with active lupus nephritis.
Liu G; Wang H; Le J; Lan L; Xu Y; Yang Y; Chen J; Han F
Lupus; 2019 Mar; 28(3):283-289. PubMed ID: 30682900
[TBL] [Abstract][Full Text] [Related]
2. Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis.
Kwon OC; Park Y; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Clin Rheumatol; 2019 Jan; 38(1):235-241. PubMed ID: 30094751
[TBL] [Abstract][Full Text] [Related]
3. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
4. Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.
Sigdel MR; Kafle MP; Shah DS
BMC Nephrol; 2016 Oct; 17(1):145. PubMed ID: 27717323
[TBL] [Abstract][Full Text] [Related]
5. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
[TBL] [Abstract][Full Text] [Related]
8. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O
BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196
[TBL] [Abstract][Full Text] [Related]
9. Remission of proteinuria under therapeutic intervention and the renal outcomes in Japanese patients with lupus nephritis class III and IV.
Okabayashi Y; Tsuboi N; Haruhara K; Kanzaki G; Koike K; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
Mod Rheumatol; 2020 Jan; 30(1):125-131. PubMed ID: 30557058
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histopathological features and short-term outcomes of lupus nephritis: a prospective study of 100 Egyptian patients.
Saleh M; Eltoraby EE; Tharwat S; Nassar MK
Lupus; 2020 Jul; 29(8):993-1001. PubMed ID: 32493152
[TBL] [Abstract][Full Text] [Related]
11. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.
Izmirly PM; Kim MY; Carlucci PM; Preisinger K; Cohen BZ; Deonaraine K; Zaminski D; Dall'Era M; Kalunian K; Fava A; Belmont HM; Wu M; Putterman C; Anolik J; Barnas JL; Diamond B; Davidson A; Wofsy D; Kamen D; James JA; Guthridge JM; Apruzzese W; Rao DA; Weisman MH; ; Petri M; Buyon J; Furie R
Arthritis Res Ther; 2024 Feb; 26(1):54. PubMed ID: 38378664
[TBL] [Abstract][Full Text] [Related]
13. Elevated Creatinine Clearance in Lupus Nephritis patients with Normal Creatinine.
Wang S; Wang F; Wang X; Zhang Y; Song L
Int J Med Sci; 2021; 18(6):1449-1455. PubMed ID: 33628102
[No Abstract] [Full Text] [Related]
14. Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis.
Parodis I; Adamichou C; Aydin S; Gomez A; Demoulin N; Weinmann-Menke J; Houssiau FA; Tamirou F
Rheumatology (Oxford); 2020 Nov; 59(11):3424-3434. PubMed ID: 32353879
[TBL] [Abstract][Full Text] [Related]
15. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F
Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
[TBL] [Abstract][Full Text] [Related]
17. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
[TBL] [Abstract][Full Text] [Related]
18. Diffuse segmental and pure diffuse global proliferative glomerulonephritis: different patterns of class IV lupus nephritis.
Xu S; Liu Z; Chen H; Zeng C; Zhang H; Liu Z; Hu W
Clin Nephrol; 2014 Jun; 81(6):411-8. PubMed ID: 25017669
[TBL] [Abstract][Full Text] [Related]
19. Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis.
Won J; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Lupus; 2019 Oct; 28(11):1294-1301. PubMed ID: 31583978
[TBL] [Abstract][Full Text] [Related]
20. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
